Savolitinib Induced Pathological Complete Response in Non-small Cell Lung Cancer with MET Amplification: A Case Report

Savolitinib Induced Pathological Complete Response in Non-small Cell Lung Cancer with MET Amplification: A Case Report

Mesenchymal-epithelial transition factor (MET) gene mutation is a large class of mutations commonly seen in non-small cell lung cancer (NSCLC). MET mutation includes subtypes such as MET exon 14 skipping mutation (METex14m) and MET amplification (METamp). For advanced NSCLC with METex14m, Savolitini...

Full description

Saved in:
Bibliographic Details
Main Authors: Meng LU, Ran ZHANG, Baiwei LI, Haidi XU, Yongkuan GUO, Jian YOU, Bingsheng SUN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2024-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
neoadjuvant targeted therapy
met amplification
savolitinib
pathological complete response
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2024.102.36
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items